These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2410714)

  • 1. Neuroinhibitory effects of SK&F 85174, a novel dopamine receptor agonist.
    Blumberg AL; Wilson JW; Hieble JP
    J Cardiovasc Pharmacol; 1985; 7(4):723-32. PubMed ID: 2410714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SK&F 89124, a potent and selective agonist at prejunctional dopamine receptors.
    Hieble JP; Sulpizio AC; Sarau HM; Flaim KE; Blumberg AL; McCafferty JP; Zeid RL
    Fundam Clin Pharmacol; 1989; 3(6):621-42. PubMed ID: 2575569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist.
    Hahn RA; Wardell JR; Sarau HM; Ridley PT
    J Pharmacol Exp Ther; 1982 Nov; 223(2):305-13. PubMed ID: 6127401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on vascular dopamine receptors with the dopamine receptor agonist: SK&F 82526.
    Ohlstein EH; Zabko-Potapovich B; Berkowitz BA
    J Pharmacol Exp Ther; 1984 May; 229(2):433-9. PubMed ID: 6143817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal vascular activity of SK&F 38393 and dopamine in anesthetized dogs.
    Hahn RA; Wardell JR
    J Cardiovasc Pharmacol; 1980; 2(5):583-93. PubMed ID: 6157951
    [No Abstract]   [Full Text] [Related]  

  • 6. Suppression of sympathetic ganglionic neurotransmission by the selective dopamine-1 receptor agonist fenoldopam (SK&F 82526) in the anesthetized dog.
    Shebuski RJ; Fujita T; Smith JM; Kopaciewicz LJ; Blumberg AL; Hieble JP
    J Pharmacol Exp Ther; 1985 Dec; 235(3):735-40. PubMed ID: 2867207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic effects of selective dopamine receptor agonists in the rat and dog.
    Hieble JP; Owen DA; Harvey CA; Blumberg AL; Valocik RE; DeMarinis RM
    Clin Exp Hypertens A; 1987; 9(5-6):889-912. PubMed ID: 2887313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additional evidence for functional subclassification of alpha-2 adrenoceptors based on a new selective antagonist, SK&F 104856.
    Hieble JP; Sulpizio AC; Edwards R; Chapman H; Young P; Roberts SP; Blackburn TP; Wood MD; Shah DH; Demarinis RM
    J Pharmacol Exp Ther; 1991 Nov; 259(2):643-52. PubMed ID: 1682482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different dopamine receptor subtypes mediate the neurogenic vasodilation produced by fenoldopam and SK & F 85174 in the dog hindlimb.
    Lokhandwala MF; Watkins HO; Dlewati A
    Eur J Pharmacol; 1987 Nov; 143(3):383-90. PubMed ID: 2891555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SCH 23390 and SK&F 83566 are antagonists at vascular dopamine and serotonin receptors.
    Ohlstein EH; Berkowitz BA
    Eur J Pharmacol; 1985 Jan; 108(2):205-8. PubMed ID: 3884345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of SK&F 85174, a DA-1/DA-2 receptor agonist, on pre- and postganglionic sympathetic neurotransmission to the heart.
    Dlewati A; Watkins HO; Lokhandwala MF
    Eur J Pharmacol; 1989 May; 164(2):197-203. PubMed ID: 2569408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine agonists related to 3-allyl-6-chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-1H-3-benzaz epi ne-7, 8-diol. 6-Position modifications.
    Ross ST; Franz RG; Gallagher G; Brenner M; Wilson JW; DeMarinis RM; Hieble JP; Sarau HM
    J Med Chem; 1987 Jan; 30(1):35-40. PubMed ID: 3806602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prejunctional inhibitory effect of a dopamine D-2 agonist, N-0437, on vascular adrenergic responses.
    Friedman DJ; Budai D; Krause DN; Duckles SP
    J Pharmacol Exp Ther; 1989 Sep; 250(3):853-9. PubMed ID: 2674420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective alpha-2 adrenoceptor blockade by SK&F 86466: in vitro characterization of receptor selectivity.
    Hieble JP; DeMarinis RM; Fowler PJ; Matthews WD
    J Pharmacol Exp Ther; 1986 Jan; 236(1):90-6. PubMed ID: 2867217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic characterization of SK&F 104078, a novel alpha-2 adrenoceptor antagonist which discriminates between pre- and postjunctional alpha-2 adrenoceptors.
    Hieble JP; Sulpizio AC; Nichols AJ; Willette RN; Ruffolo RR
    J Pharmacol Exp Ther; 1988 Nov; 247(2):645-52. PubMed ID: 2903236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The central effects of a novel dopamine agonist.
    Setler PE; Sarau HM; Zirkle CL; Saunders HL
    Eur J Pharmacol; 1978 Aug; 50(4):419-30. PubMed ID: 568069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FPL 63012AR: a potent D1-receptor agonist.
    Smith GW; Farmer JB; Ince F; Matu K; Mitchell PD; Naya I; Springthorpe B
    Br J Pharmacol; 1990 Jun; 100(2):295-300. PubMed ID: 1974159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agonist and antagonist properties of benzazepine and thienopyridine derivatives at the D1 dopamine receptor.
    O'Boyle KM; Gaitanopoulos DE; Brenner M; Waddington JL
    Neuropharmacology; 1989 Apr; 28(4):401-5. PubMed ID: 2568596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for heterogeneity between pre- and postjunctional alpha-2 adrenoceptors using 9-substituted 3-benzazepines.
    Daly RN; Sulpizio AC; Levitt B; DeMarinis RM; Regan JW; Ruffolo RR; Hieble JP
    J Pharmacol Exp Ther; 1988 Oct; 247(1):122-8. PubMed ID: 2902209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal dopamine receptors of the rabbit ear artery: pharmacological characterization of the receptor.
    Hieble JP; Nelson SH; Steinsland OS
    J Auton Pharmacol; 1985 Jun; 5(2):115-24. PubMed ID: 4019529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.